Literature DB >> 7034757

Spinal analgesia with hyperbaric bupivacaine: effects of volume of solution.

K O Sundnes, P Vaagenes, P Skretting, B Lind, H H Edstróm.   

Abstract

The effects of 0.5% bupivacaine 1.5, 2 and 3 ml in 8% glucose was compared in a double-blind study involving 30 patients undergoing spinal analgesia. The time to the onset of maximum segmental spread of analgesia was approximately 15 min for all three volumes. Cephalad spread of analgesia was related to the volume used: 1.5 ml reached T10, 2 ml T8 and 3 ml T7. The duration of analgesia increased with increasing volume, 3 ml producing analgesia in T8-T12 for 1.5-2 h, and in the lumbar region for 2.5-3 h. Increasing the volume increased the extent of motor blockade and speeded up its onset. Significant decreases in arterial pressure were observed in the 2- and 3-ml groups. The changes in heart rate were moderate and not correlated with the amount of drug. Spinal headache occurred in two patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7034757     DOI: 10.1093/bja/54.1.69

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  The selection of the regional anaesthesia in the transurethral resection of the prostate (TURP) operation.

Authors:  S Ozmen; A Koşar; S Soyupek; A Armağan; M B Hoşcan; C Aydin
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

2.  A randomized controlled trial comparing haemodynamic stability in elderly patients undergoing spinal anaesthesia at L5, S1 versus spinal anaesthesia at L3, 4 at a tertiary African hospital.

Authors:  Vitalis Mung'ayi; Karen Mbaya; Thikra Sharif; Dorothy Kamya
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

Review 3.  Spinal anaesthesia.

Authors:  J A Wildsmith
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

4.  Comparison of hyperbaric solutions of bupivacaine and tetracaine during continuous spinal anaesthesia.

Authors:  E F Van Gessel; B Miege; A Forster; G Salvaj; M Fathi; Z Gamulin
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.